IGEM Therapeutics Awarded “Best Start-up Biotech Company” at the 2018 OBN Awards
October 15, 2018
London, 12 October 2018 – IGEM Therapeutics (IGEM), an immuno-oncology company developing novel immunoglobulin E (IgE) antibodies to treat cancer, today announced that it has